In an exciting research project, a team of scientists in the United States has discovered a new molecule in the blood of snakes that could provide innovative solutions to weight loss and age-related muscle loss challenges. This discovery opens up new possibilities for developing medications that help control appetite without the common side effects associated with many current obesity drugs.
Constrictor snakes, which are among the largest snakes and can measure up to seven meters in length, have the ability to consume massive meals, such as a whole deer, and can then abstain from food for periods extending over months or even years. The researchers avoided the trap of mimicking the snakes' dietary system; instead, they focused on understanding how these creatures can fast and eat voraciously without negatively impacting their heart or muscle health over the long term.
Details of the New Discovery
The discovered molecule, known as para-tyramine-O-sulphate (pTOS), was identified by a group of researchers led by Professor Leslie Leinwand at the University of Colorado Boulder, while studying the digestive system of these non-venomous snakes found in Africa, Asia, and Australia. The results of this research were published in collaboration with researchers from Stanford Medicine and Baylor University in the journal Nature Metabolism.
Experiments showed that a snake's heart expands by 25% after consuming a meal, while its metabolic rate rises up to 4000 times to assist in digesting the food, accompanied by a surge in the levels of pTOS in the blood exceeding 1000-fold.
Background & Context
Attempts to address obesity often involve medications such as Ozempic and Wegovy, which target the GLP-1 hormone that helps the body feel full by slowing down digestion and regulating blood sugar levels. However, these drugs come with a range of side effects, including nausea and digestive discomfort.
In experiments conducted on mice, it was observed that doses of pTOS resulted in reduced appetite, leading to weight loss and improved control over food intake without significant changes in activity, energy expenditure, or blood sugar levels.
Impact & Consequences
This discovery introduces a new biological mechanism that contributes to the body's sense of fullness after eating, which could lead to the development of future treatments that naturally reduce hunger and assist in weight management. It also highlights the crucial role of gut bacteria in shaping metabolism and signaling to the brain.
However, it is important to note that these findings are still in their early stages, as pTOS has only been tested on mice, indicating a significant amount of investigation remains to explore its effects in humans.
Regional Significance
Obesity is a pressing health issue in the Arab world, affecting a large percentage of the population and leading to chronic health problems. This discovery could contribute to the development of new strategies to combat obesity in the region and gives hope to individuals facing weight challenges.
Ultimately, this research is a starting point for a deeper understanding of the body's mechanisms related to appetite and obesity, opening the door to hope for more effective future treatments with fewer side effects.